Comparison of Changes in Tumor Burden in 68Ga-PSMA-11 PET/CT and 177Lu-PSMA SPECT/CT in Metastatic Castration-resistant Prostate Cancer

NCT06461689 · clinicaltrials.gov ↗

COMPLETED

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer Metastatic

Interventions

DRUG: 177Lu-PSMA-617

Sponsor

Central Hospital, Nancy, France